Statistics for ClearPoint Neuro (id:5437 CLPT)

Valuation metrics

Market cap

310.05M

Enterprise value

284.17M

Trailing P/E (ttm)

-12.18

Forward P/E

-18.43

PEG ratio

-18.43

Price/Sales (ttm)

10.19

Price/Book (mrq)

10.69

Enterprise Value/Revenue

9.34

Enterprise Value/EBITDA

-15.85

Overview

Shares outstanding

27.58M

Float

25.42M

Shares short

687.56K

% Held by insiders

0.08%

% Held by institutions

0.30%

Average volume (10 days)

363.26K

Average volume (90 days)

Price summary

52-Week low

5.11

52-Week high

14.13

52-Week change

46.53%

Beta

1.11

50-Day moving average

12.05

200-Day moving average

8.26

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

July 27th, 2016

Ex-dividend date

Last split factor

2:1

Last split date

July 27th, 2016

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-59.64%

Operating margin

-63.68%

Operational effectiveness

Return on assets

-28.04%

Return on equity

-68.36%

Income statement

Revenue (ttm)

1.16

Revenue per share (ttm)

1.16

Quarterly revenue growth (yoy)

Gross profit (ttm)

13.61M

EBITDA

-17,925,000.00

Net income to common (ttm)

-18,147,000.00

Diluted EPS (ttm)

-0.69

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

21.57M

Total cash per share (mrq)

0.78

Total debt (mrq)

3.69M

Total Debt/Equity (mrq)

12.74

Current ratio (mrq)

454.50%

Book value per share (mrq)

1.05

Cash flow

Cash flow statement

-8,876,000.00

Levered free cash flow (LFCF)

-1,287,000.00